Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
There is no link not till 12:30 or after... will likely be on CytoDyn's website or one of their Investor Relations affiliates... this is a pre-recorded interview:
https://www.cytodyn.com/about-cytodyn
In 10 minutes or so from now.
All of CytoDyn's Investor Relations entities are listed on OTCMarkets site (see near bottm of page):
https://www.otcmarkets.com/stock/CYDY/profile
When one finds a diamond in the rough... or should I say gutter... best to hold onto that rare gem as not many to even look at much less get a sparkle from!
Only good thing out of yesterday is being able to collect more gems to make a crown!
And btw, with our long list of ailments that Leronlimab can tackle, if any med pros can please tell whether Leron might handle/help with epilepsy?
Would be deserved for such scum...
No need to read the garbage... all it was... some entity felt threatened!!
It's all about getting the PROOF of the science... this extensive, well researched article by Dr. Gupta is worth a replay:
https://www.cnn.com/2020/06/27/health/science-by-press-release-gupta/index.html
It's a SUPERB read on the truth of the matter!
As a retired journalist, I've yet to find a more comprehensive article with the most valid of attribution and quotes from the pros who should absolutely know... it is indeed all about the science and more importantly for the masses in this pandemic, the published science to come in medical journals after peer review of trial results and papers submitted.
Bravo and thank you to CytoDyn for continuing to do it by the book, despite all the hype of other companies and their so-called Covid-19 saving drugs and products.
I've told my husband, if I'm ever hospitalized with covid or cancer or possibly anything else, please do all possible at whatever cost to get me Leronlimab .... the miracle, the homerun, the best of the best drug!!!
On a nother note... has anyone seen we (CytoDyn) now have 20 employees... seems the company's bringing on a newcomer weekly... maybe they have the new '"Commercial Officer" on board by now:
Quote:
Employees 20 as of 06/16/2020
https://www.otcmarkets.com/stock/CYDY/profile
Seeing this on my TD Ameritrade account just now (albeit, literally yesterday's news):
https://www.prnewswire.com/news-releases/why-biomarkers-for-cancer-drug-development-are-becoming-increasingly-imperative-301085546.html
This is in my neck of the woods... and while it's just briefly reported here, it's a start to getting our name out there. Wish we still just call it Pro 140 ...
Good seeing it on CytoDyn's website also:
https://www.cytodyn.com/investors/news-events/in-the-news
https://www.wtnh.com/news/health/coronavirus/yale-infectious-disease-doctor-weighs-in-on-hiv-drugs-promise-for-covid-19-and-mask-safety/
Notice, they UPDATED this article early this morning... think they added the following as that is not stated in their produced news story:
Sorry, here you go:
https://www.ajc.com/lifestyles/health/for-some-with-covid-symptoms-can-linger-for-weeks-even-months/0rzLkWZWeXh0D2y3ezEqcN/
And now CytoDyn has it on their site as well:
https://www.cytodyn.com/investors/news-events/in-the-news
This made it on CytoDyn's website today:
https://www.ajc.com/lifestyles/health/for-som...2y3ezEqcN/
Great article!
First hand accounts and testimonials... especially published like this... and from our doctor Recknor are the best to convince all of what Leronlimab can do and does: save lives and treat Covid-19 patients!! Might be the only thing that helps our economy get back on track also....
Published papers and a nod from the FDA should allow the world to find out there's nothing better for Covid-19 than Leronlimab
Competition has nothing on Leron... no other company has had as many Covid-19 EINDs (70) as CytoDyn
No other company has the efficacy especially 'safety' factor with more than 900 patients (HIV)... CytoDyn/Leronlimab ahead of the pack, and the FDA knows this...
Dr. Lalezari recently (6/2/20) again said:
I suspect it's the doctors and hospitals and medical community that will make this small pharma CytoDyn a giant of the industry in the weeks and months ahead...
And indeed the human element makes the life saving Leronlimab story one for the ages... Leron becomes the 21st century's 'penicillin' ....
These CCs keep getting better and better; just so much going on with our gem!
I believe it was a friend of Dr. Kelly... Hero Dr. Christopher Recknor (treated himself and enrolled patients):
https://health.usnews.com/doctors/christopher-recknor-187611
Another hero along with our original Hero Doc Harish Seethamraju of Montefiore Medical Center :
Dr. Nicholas Agreski of Southeast Georgia Health Systems (used LL on three of his patients) who is working with Dr. Kush Dhody to publish papers!
https://www.google.com/maps/uv?hl=en&pb=!...CnoECBUQBg
https://www.sghs.org/Find-a-Provider/A/Nichol...-M-D-.aspx
Call replay is now available:
A replay of the conference call will be available until July 11, 2020. To access the replay, interested parties may dial 877-660-6853 (US) / 201-612-7415 (international) and enter conference identification number 13705221.
Call was BRILLIANT!
\
The upcoming CC is likely not about the trials, studies, results or numbers but with Dr. Scott Kelly on a CC for a first time it's probably about creation of the "powerful Science Advisory Board" Dr. Pourhassan mentioned on the 5/26 CC by CytoDyn when Dr. Michael Mulholland also noted expanding the employee base (CytoDyn has been listed as having 15 employees on OTC Markets)... also maybe the hiring of a "Commercial Officer."
I believe on a number of calls, Dr. Pourhassan brought up Dr. Kelly regarding a few important matters:
Kelly apparently brought in Dr. Bruce Patterson
Kelly apparently brought back Dr. Nitya Ray
Kelly apparently kept Pourhassan in the game, helping him in challenging times (also willing to excercise his warrants in May)
Kelly apparently has a lot to do with getting manufacturing
Kelly apparently has Pourhassan's ear and full attention
About Dr. Scott Kelly:
April 2017: Director
Dec. 2018: Chairman of the Board
July 2019: Chief Science Officer
April 2020: Chief Medical Officer and Head of Business Development
I actually thought I saw something about Dr. Pourhassan making $1.5M a year and deservingly, imo... hope he didn't take a cut now, after all he's already done and been doing.
Saltz -- you deserve more than one follow but that's all that's allowed so you got #38 for the many rational, intelligent and fact based posts you've produced here... posting since 2016 no less and seems you've been in for around eight years, wow!
Frivolous anyway but YEAH
Exact words of Dr. Pourhassan from 6/2/2020 CC:
AWESOME!
This is an important publication for CytoDyn to be in, imho (wish they would do a more comprehensive report/article on Leronlimab):
http://www.healthday.com/contact-healthday.html
Then their articles go out to thousands of entities:
While there are more than 150 companies/Pharmas working on Covid-19 which isn't going away any time soon... there are but a handful continuously being mentioned... and for CytoDyn/Leronlimab to be among them tells me there are numerous positive potentials for our little CYDY:
Today's CytoDyn news is making the rounds, and there are replays:
https://www.nasdaq.com/articles/cytodyn-files...facts-2020
https://seekingalpha.com/news/3578879-cytodyn...la-for-hiv
https://www.usnews.com/news/health-news/artic...he-economy
https://www.omaha.com/money/wall-street/cytod...5c3c3.html
https://tylerpaper.com/ap/business/cytodyn-fi...5c07c.html
https://www.bakersfield.com/ap/news/cytodyn-t...8c6ae.html
https://www.einnews.com/pr_news/518358933/cyt...t-approval
https://forextv.com/top-news/cytodyn-files-re...-approval/
And now my fav... HealthDay ... while it's just a replay and I suppose all due to that other drug (that's not working) we get this mention but this is an article that goes out in numerous health related publications (actually thousands):
https://consumer.healthday.com/infectious-dis...58141.html
Hopefully the right folks... particularly physicians and the medical community... are reading and preferably taking action.
Thanks for getting this thought-provoking analysis and commentary by Jiro posted here... worthy of another read and contemplation...
Should be stickied for referring to when there's negativity... remember, Leronlimab is here to stay and save lives!
All over the place.... you're so good, Leronlimab!
http://pennstatehershey.adam.com/content.aspx?pid=35&gid=13461
https://www.bioworld.com/articles/435319-other-news-to-note-for-may-26-2020?v=preview
And let's not forget this one... just out to the community:
https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-therapeutics-tracker
It's here to stay for quite a while... but thank goodness, so is Leronlimab!
And here's more about our beloved Leronlimab making its way around the globe...
http://www.koreabiomed.com/news/articleView.html?idxno=8362
And btw on another note, I think Dr. Pourhassan is a gem of a CEO among the trash of the OTC...more than 10k... anyone who doesn't like it is welcome to exit... for me, I was buying on the dip this morning.
There is no perfection in this world and everyone has faults but having said that... there's been nothing wrong with Dr. Pourhassan's informative, relatively lengthy, open and candid presentations/calls... would you rather stay in the dark like 99% of the OTCs...
The only reason Leronlimab... the science... is even around is because Dr. Pourhassan resurrected it. And for that, HE gets all the credit!!!
Summary for anyone to understand... great!
Nicely said... and agree on all points...
Already available
Thank you for being on top of this JB!
Just a simple google search produces the following:
https://patents.justia.com/assignee/cytodyn-inc
And here's more for Dr. Bruce Patterson/IncellDX who has 87 patents:
https://patents.justia.com/inventor/bruce-k-patterson
No one better than Dr. Pourhassan for CytoDyn/leronlimab... and putting dollars behind that, I've picked up a few thousand more lovely CYDY shares today... thanks to whoever gave them up at 3.10-3.12 ....
Worth repeating today's Proactive interview on this site too... basically detailing this morning's PR but there's some other news within it:
Dr. Jacob Lalezari:
Whether Remdesivir is an anti-viral as it claims remains "up in the air' ... have indication it reduces hospital stay from 15 to 11 days... want to see clear mortalitity benefits, time to discharge or return to good health.
Dr. Nader Pourhassan:
The UK is almost ready to be a site for us (trial site)... Mexico is close to being another site and of course a number of sites in the U.S.
Want to show Leronlimab is an immune corrective drug, not just for Covid-19 but for influenza and other indications (22 different cancers, HIV etc.).
All about correcting the immune system which can then handle all of these indications... we think results are going to be "very impressive."
Dr. Lalezari:
Follow up on safety... we know Remdesivir is a drug that can cause liver and kidney toxicity or problems (injury) so a lot of patients are not eligible to receive Rem... precisely because the disease itself (covid) is causing that organ dysfunction. We think inflamation is being driven by RANTES, the same immune chemical that's driving the entire illness of Covid-19 and is the "master switch" that we have been very fortunate with Leronlimab to shut down. After all the testing we have done with more than 800 HIV patients and with cancer and with covid-19 now, we can say there is no real serious adverse effect we can point to from Leronlimab.
Dr. Pourhassan:
Heard in the news Gilead will have 300K doses of Rem for patients this year. We have 1.2M to be delivered at the end of June or early July from Samsung Biologics alone and can ensure having more... two or three times that once we get good information from the FDA and what they think of our results.
When do you plan to submit this trial design?
Shooting for the end of this week or end of next week... we're working hard on all other avenues; we have so many other things we're doing right now.
He was happy with Dr. Patterson's two-hour presentation last night and explanation of how well Leron is working.
Not just because testing's already underway but also because Leronlimab is multifaceted... that is it quiets the cytokine storm, improves the immunologic homeostatis and decreases the viral load.
On top of all of that, no serious negative side effects make Leronlimab in a class of its own... unique in targeting numerous areas... no wonder it may some day be known as the 'miracle' drug as it treats a multitude of ailments (HIV, at least 22 solid cancers, now covid-19 ... ).
I'll point out that Beckman Coulter is a distributor of IncellDX, Dr. Patterson's company.
https://incelldx.com/contact-us/
In fact, two of the names on the paper that went to medical/health preprint services (medRxiv & Research Square) are from Beckman Coulter:
Alena Lelic, Lama Kdouh
Back to medRxiv ... interesting comments by posters at bottom:
https://www.medrxiv.org/content/10.1101/2020....20084673v1
And here's the Research Square preprint:
https://www.researchsquare.com/article/rs-26517/v1
Along with this the Nature info on Leronlimab :
https://www.nature.com/search?q=leronlimab
Yes, all good news... today I was able to disclose CytoDyn information to a friend who has some big medical connections in the South (besides Novant Health) so hopefully we spread the word about our phenomenal Leronlimab!
New Proactive news:
https://www.proactiveinvestors.com/companies/news/919745/cytodyn-partner-to-offer-free-testing-for-coronavirus-linked-childhood-inflammatory-disease-919745.html
BLA (HIV) completed on part of CytoDyn and waiting for FDA reply the planning to file priority review next week.